Cjc-1295 (modified GRF 1-29) is a Growth Hormone releasing hormone analog

Ipamorlin is a  Ghrelin/Growth hormone secretagogue receptor agonist. This research combination pairs CJC-1295, a synthetic analogue of Growth Hormone Releasing Hormone (GHRH), with Ipamorelin, a selective growth hormone secretagogue. Preclinical studies have examined CJC-1295 for its extended half-life compared to native GHRH and its studied interactions with pituitary receptors. Ipamorelin has been investigated for its selectivity in growth hormone release pathways with minimal impact on cortisol or prolactin levels in animal research models. Frequently studied together in laboratory settings.